TCON SELL by Puissance Life Science Opportunities Fund VI — Form4
TCONPuissance Life Science Opportunities Fund VI sold Tracon Pharmaceuticals, Inc. shares — SEC Form 4SELLTracon Pharmaceuticals, Inc.
Puissance Life Science Opportunities Fund VI, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold4,326 shares at $1.21 ($5K) on 2018-11-29, disclosed to the SEC on 2018-12-03.